CDC

Latest Issue of OR Manager
February 2022

CDC: Those recovered from COVID-19 less likely than vaccinated to get Delta variant

Editor's Note The Centers for Disease Control and Prevention, on January 19, released a study showing that in New York and California, both vaccination and prior infection offered protection against COVID-19, but those who had recovered from COVID-19 were less likely than vaccinated individuals to get infected during the Delta…

Read More

By: Judy Mathias
January 20, 2022
Share

CDC: Racial, ethnic disparities in receipt of COVID-19 treatments

Editor's Note This study from the Centers for Disease Control and Prevention (CDC) finds disparate monoclonal antibody (mAb) treatment of COVID-19 in Hispanic, Black, Asian, and Other race patients, compared to non-Hispanic and White patients. Differences in treatment with dexamethasone and remdesivir were less apparent. Analyzing data from 41 healthcare…

Read More

By: Judy Mathias
January 18, 2022
Share

Supreme Court blocks federal government’s vaccine mandate for large workplaces but not for healthcare facilities

Editor's Note The Supreme Court on January 13 blocked the federal government’s COVID-19 vaccine-or-test requirement for workplaces with 100 or more employees, but the Court is allowing a vaccine mandate for healthcare workers at facilities that receive Medicaid and Medicare funds. The order covers more than 17 million healthcare workers…

Read More

By: Judy Mathias
January 13, 2022
Share

Sponsored Message

NIOSH rescinds approval for ALG Health’s N95 respirator masks

Editor's Note The National Institute for Occupational Safety and Health (NIOSH) has honored a request by N95 respirator mask manufacturer, ALG Health (Bryan, Ohio), to rescind all respirator approvals issued to ALG Health, effective immediately. As of January 6, any of the following ALG Health N95 respirators marked with a…

Read More

By: Judy Mathias
January 13, 2022
Share

Meta-analysis finds high global percentage of asymptomatic COVID-19 infections

Editor's Note This study by Chinese researchers finds a high percentage of asymptomatic COVID-19 infections worldwide, which highlights the potential transmission risk of asymptomatic infections in communities. In this review and meta-analysis of 95 studies, which include nearly 30 million individuals undergoing testing, the percentage of asymptomatic infections was 0.25%…

Read More

By: Judy Mathias
December 16, 2021
Share

Effectiveness of mRNA vaccines against COVID-19

Editor's Note This case-controlled study by researchers from White River Junction Veterans Affairs Medical Center, White River Junction, Vermont, and Dartmouth School of Medicine, Hanover, New Hampshire, finds that mRNA vaccine effectiveness against COVID-19 decreases significantly after about 6 months. In this analysis of 14,238 male veterans aged 65 or…

Read More

By: Judy Mathias
December 16, 2021
Share

Sponsored Message

CDC: Surveillance of Omicron variant in US

Editor's Note On December 1, the first case of COVID-19 attributed to the Omicron variant was reported in the US, according to the Centers for Disease Control and Prevention (CDC). As of December 8, Omicron variant cases had been reported in 22 states, including some that indicated community transmission. Of…

Read More

By: Judy Mathias
December 15, 2021
Share

Change in volume of surgical procedures during COVID-19 pandemic

Editor's Note In this study, researchers from Stanford University School of Medicine find that the initial COVID-19 shutdown from March through April 2020 resulted in a decrease in surgical volume to nearly half of baseline rates. After the reopening, surgical volume rebounded to 2019 levels, and the trend was maintained.…

Read More

By: Judy Mathias
December 8, 2021
Share

CDC confirms first US case of Omicron COVID-19 variant

Editor's Note The Centers for Disease Control and Prevention, on December 1, issued a statement that the California and San Francisco Departments of Public Health have confirmed that a recent case of COVID-19 in an individual in California was caused by the Omicron variant (B.1.1.529). The individual, who has mild…

Read More

By: Judy Mathias
December 2, 2021
Share

CDC recommends Pfizer/BioNTech pediatric COVID-19 vaccine

Editor's Note The Centers for Disease Control and Prevention (CDC), on November 2, recommended broad use of the Pfizer/BioNTech COVID-19 vaccine for children ages 5 to 11. Distribution of the vaccine to clinics, children’s hospitals, and pediatricians’ offices across the country have started, with plans to scale up to full…

Read More

By: Judy Mathias
November 4, 2021
Share

Get OR Manager Updates

Sign Up Now
Latest Issue of OR Manager
February 2022
Video Spotlight
Live chat by BoldChat